Clinical Trials Logo

Rabies Prevention clinical trials

View clinical trials related to Rabies Prevention.

Filter by:
  • Completed  
  • Page 1

NCT ID: NCT01107275 Completed - Rabies Prevention Clinical Trials

Early Rabies Vaccine Immunization in Primary School Children

I49P1
Start date: November 2002
Phase: Phase 3
Study type: Interventional

700 male and female healthy school-children (age 5 to 8) in Thailand were randomized to receive 2 or 3 primary rabies vaccine doses (PCECV, Rabipur) given intradermally in a dose of 0.1mL into the skin in the deltoid region. In a subset of 100 children blood was taken for rabies virus neutralizing antibody determination on day 49. All subjects were randomized to receive 2 booster doses (the recommended vaccination schedule for pre-immunized individuals in case of an exposure) on days 0 and 3, one, three or five years later. Blood was taken before and after booster for up to one year.Safety and tolerability of the vaccine was assessed and persistence of immune response up to 1 year after the booster doses.

NCT ID: NCT01044199 Completed - Rabies Prevention Clinical Trials

Study of Intradermal Administration of PCEC Rabies Vaccine

Rabies-ID
Start date: February 2009
Phase: N/A
Study type: Interventional

The purpose of this study is to determine immunogenicity and safety of intradermal administration of the PCEC rabies vaccine in adults.